Page last updated: 2024-08-25

rosiglitazone and Sclerosis

rosiglitazone has been researched along with Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biçak, S; Bozkurt, D; Duman, S; Ok, E; Sen, S; Sezak, M; Taskin, H	1

Other Studies

1 other study(ies) available for rosiglitazone and Sclerosis

Article	Year
Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2008, Volume: 24 Topics: Animals; Female; Peritoneal Dialysis; Peritoneal Diseases; Peritoneum; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Wistar; Rosiglitazone; Sclerosis; Thiazolidinediones	2008

Article

Year

Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2008, Volume: 24

Topics: Animals; Female; Peritoneal Dialysis; Peritoneal Diseases; Peritoneum; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Wistar; Rosiglitazone; Sclerosis; Thiazolidinediones

2008